Creative Biolabs-Immuno-oncology

Anti-MERTK (clone Y7YH7) SynExpress pU-Cy2-I17-B Modified CD8+ T cells (CAT#: ITS-1224-CR1126)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target MERTK (clone Y7YH7). We employs the pX330 (pUC-Cy2-IL-17-BamHI) vector components and the SynExpress system of the Introns Knock-in/Negative feedback for a robust and sustained response against cancers.
Host
Mouse
Target
MERTK
Clone
Y7YH7
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy2
Promoter
pUC
Effector Gene
IL-17
Insertion Sites
BamHI
Gene Modification
Knock-in
Modification Domain
Introns
Carrier Type
pX330
Transformation Accuracy
0.93
Cell Culture
Aseptic Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving